000 | 01229 a2200349 4500 | ||
---|---|---|---|
005 | 20250518090818.0 | ||
264 | 0 | _c20210514 | |
008 | 202105s 0 0 eng d | ||
022 | _a1365-2133 | ||
024 | 7 |
_a10.1111/bjd.19013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGisondi, P | |
245 | 0 | 0 |
_aSwitching from one infliximab biosimilar (CT-P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis. _h[electronic resource] |
260 |
_bThe British journal of dermatology _c08 2020 |
||
300 |
_a397-398 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aBiosimilar Pharmaceuticals _xtherapeutic use |
650 | 0 | 4 | _aDrug Substitution |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfliximab _xtherapeutic use |
650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aVirga, C | |
700 | 1 | _aPiaserico, S | |
700 | 1 | _aMeneguzzo, A | |
700 | 1 | _aOdorici, G | |
700 | 1 | _aConti, A | |
700 | 1 | _aGirolomoni, G | |
773 | 0 |
_tThe British journal of dermatology _gvol. 183 _gno. 2 _gp. 397-398 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.19013 _zAvailable from publisher's website |
999 |
_c30706869 _d30706869 |